Zaurito P, Moschini M, Briganti A, Montorsi F, et al. Re: Douglas M. Dahl, Joseph P. Rodgers, William U. Shipley, et al. Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926. J Clin Oncol 2024;42:4095-102. Eur Urol 2025 May 3:S0302-2838(25)00250-7. doi: 10.1016/j.eururo.2025.
PMID: 40320315